In conclusion, this is the first report demonstrating that TAC has protective effects on LPS‐induced AKI by inhibiting TLR4/MyD88/NF‐κB signalling pathway and preventing podocyte dysfunction. The gene discussed is MYD88; the disease is acute kidney injury.